Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > biguanides market
Get a free sample of Biguanides Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Biguanides Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The biguanides industry is characterized by a dynamic interplay among pharmaceutical companies striving to capture a significant share. Companies such as Merck & Co., Inc, Bristol-Myers Squibb Company, and Teva Pharmaceutical Industries Ltd. are notable players, with well-established product portfolios. These players are constantly involved in strategic alliances, collaborations, and market expansion initiatives to strengthen their foothold in the market.
Some of the key players operating in the biguanides industry include:
Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla Ltd., GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Merck & Co., Inc., Sanofi, Takeda Pharmaceutical Company Limited., Teva Pharmaceuticals Industries Ltd. are some of the major industry contenders.
North America biguanides industry held a revenue share of 38.2% and is set to grow significantly through 2032, driven by the significant burden of diabetes in the region.
The branded biguanides segment held a business share of 87.4% in 2023 and is poised to grow rapidly through 2032, attributed to established reputation, patent protection, physician preference, perceived quality, and patient brand loyalty.
Global biguanides industry was valued at USD 5.2 billion in 2023 and is projected to grow at a CAGR of 2.9% between 2024 and 2032, attributed to the rising number of diabetes cases globally.